Chemoinformaics analysis of Malvidin-3-O-Alpha-L-Arabinoside
Molecular Weight | 498.868 | nRot | 5 |
Heavy Atom Molecular Weight | 475.684 | nRig | 23 |
Exact Molecular Weight | 498.093 | nRing | 4 |
Solubility: LogS | -3.397 | nHRing | 2 |
Solubility: LogP | 1.168 | No. of Aliphatic Rings | 1 |
Acid Count | 1 | No. of Aromatic Rings | 3 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 57 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 2 |
nHetero | 12 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 22 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
No. of Oxygen atom | 11 | No. of Arom Bond | 17 |
nHA | 10 | APOL | 63.0782 |
nHD | 6 | BPOL | 31.7538 |
QED | 0.302 |
Synth | 4.162 |
Natural Product Likeliness | 1.759 |
NR-PPAR-gamma | 0.958 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.013 |
Pgp-sub | 0.98 |
HIA | 0.784 |
CACO-2 | -6.289 |
MDCK | 0.0000105 |
BBB | 0.091 |
PPB | 0.816233 |
VDSS | 0.953 |
FU | 0.250043 |
CYP1A2-inh | 0.048 |
CYP1A2-sub | 0.314 |
CYP2c19-inh | 0.012 |
CYP2c19-sub | 0.081 |
CYP2c9-inh | 0.002 |
CYP2c9-sub | 0.265 |
CYP2d6-inh | 0.036 |
CYP2d6-sub | 0.236 |
CYP3a4-inh | 0.006 |
CYP3a4-sub | 0.028 |
CL | 10.17 |
T12 | 0.859 |
hERG | 0.036 |
Ames | 0.685 |
ROA | 0.037 |
SkinSen | 0.125 |
Carcinogencity | 0.053 |
EI | 0.04 |
Respiratory | 0.11 |
NR-Aromatase | 0.897 |
Antiviral | Yes |
Prediction | 0.606366 |